News
B-type natriuretic peptide is released by cardiac myocytes ... If the BNP level is significantly elevated (greater than 400 pg/mL), heart failure is the likely diagnosis. Note that the degree ...
BNP levels are highly predictive of cardiac events within 6 months. In a study of 325 patients presenting with dyspnea to an emergency department, patients with BNP levels >480 pg/mL had a 51% ...
B-type natriuretic peptide (BNP) and its precursor, N-terminal pro-brain BNP (NT-proBNP) have been extensively studied for their predictive value in patients with heart failure. A systematic ...
12d
Clinical Trials Arena on MSNEmory begins enrolment for BioCardia’s trial of ischemic heart failure therapyThe trial is assessing the therapy for individuals with ischemic heart failure of minimised ejection fraction.
Background: During persistent pulmonary hypertension (PPHN) the pulmonary vascular resistance remains elevated in the ... whether serum B-type Natriuretic Peptide (BNP) is a useful biomarker ...
The initial primary use of measuring b-type natriuretic peptide (BNP ... If the BNP level is significantly elevated (> 400 pg/mL), heart failure is the likely diagnosis. Note that the degree ...
Sensitivity vs. specificity for heart failure by B-type natriuretic peptide (BNP) levels. Data from Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results